Recent News

• 04.29.2025 - 2025 American Association for Cancer Research (AACR) Annual Meeting
• 04.29.2025 - 2025 American Association for Cancer Research (AACR) Annual Meeting
• 04.15.2025 - Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction with 2025 AACR Annual Meeting
• 04.15.2025 - Foghorn Therapeutics to Host Virtual Investor Event to Review Pipeline Updates in Conjunction with 2025 AACR Annual Meeting
• 03.25.2025 - Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting
• 03.25.2025 - Foghorn Therapeutics Announces New Preclinical Data for Selective SMARCA2 Inhibitor FHD-909 and Selective CBP and EP300 Degrader Programs at 2025 AACR Meeting
• 03.06.2025 - Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook
• 03.06.2025 - Foghorn Therapeutics Provides Financial Update for 2024 and 2025 Strategic Outlook
• 03.03.2025 - TD Cowen 45th Annual Health Care Conference
• 03.03.2025 - TD Cowen 45th Annual Health Care Conference

Recent Filings

• 04.10.2025 - 4 Statement of changes in beneficial ownership of securities
• 03.24.2025 - 8-K Current report
• 03.24.2025 - EX-99.1 EX-99.1
• 03.20.2025 - 424B5 Prospectus [Rule 424(b)(5)]
• 03.20.2025 - 8-K Current report
• 03.06.2025 - EX-99.1 EX-99.1
• 03.06.2025 - 8-K Current report
• 03.06.2025 - 10-K Annual report [Section 13 and 15(d), not S-K Item 405]